News
Chimeric antigen receptor (CAR) T cells targeting CD19 have transformed the treatment of B-cell cancers, but many patients do not have long-term remission. We designed an anti-CD19 enhanced ...
Get Instant Summarized Text (Gist) A new class of small molecules, including fentomycin (Fento-1), selectively induces ferroptosis in aggressive, treatment-resistant cancer cells by targeting iron ...
Get Instant Summarized Text (Gist) An AI system can identify genetic perturbations from cell nucleus images by detecting chromatin structure changes and integrating these with gene network data ...
Malaysian infrastructure firm Gamuda Bhd. won a data-center contract worth over 1 billion ringgit ($237 million) from Google’s Malaysian affiliate, according to company filings. Gamuda said it ...
Nadya Tolokonnikova previews her stamina-testing performance in a mock prison cell at the Museum of Contemporary Art in Los Angeles. Nadya Tolokonnikova previews her stamina-testing performance in ...
Today, as part of an extended partnership with LG Energy Solution, GM announced it will produce a new battery cell that promises to lower the cost of production with a new lithium-manganese-rich ...
A French research team from Institut Curie, the CNRS and Inserm has just developed a new class of small molecules that bring about the destruction of cell membranes, and hence triggers cell death ...
GM and LG Energy Solution unveiled the “first-ever” lithium manganese-rich (LMR) prismatic EV battery cells. The new battery cells will be used in upcoming GM EV models, especially trucks and ...
As it applies to the development of cell therapies, AstraZeneca’s chief of global operations, Pam Cheng, admits that the company is a “little late to join the party.” But just because AZ has ...
A next-generation, anti-CD19 enhanced CAR T-cell therapy that secretes interleukin-18 achieved a response in 81% of lymphoma patients who failed previous CAR T-cell therapy. Duration of response ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results